SH2 Domain [amas]    
Containing [ftcn]    
m2 [qnco]    
HEPATOCELLULAR CARCINOMA [neop]    
m2 [qnco]    
Known [qlco]    
Promote [acty]    
Tumorigenesis [neop]    
dimer [chvs]    
formation [biof]    
m2 [qnco]    
investigated [ftcn]    
Containing [ftcn]    
SHP-1 [gngm]    
Decrease [qlco]    
m2 [qnco]    
Sensitivity [patf]    
Inhibiting [acty]    
Nuclear [spco]    
Related [qlco]    
function [phsf]    
m2 [qnco]    
IMMUNOPRECIPITATION [lbpr]    
IMMUNOBLOT [lbpr]    
confirmed [qlco]    
SHP-1 [gngm]    
m2 [qnco]    
Dephosphorylation [moft]    
lactate [orch]    
Production [ocac]    
Assay [lbpr]    
Cells [cell]    
Tumor Sample [tisu]    
Reverse [ftcn]    
Warburg Effect [comd]    
HEPATOCELLULAR CARCINOMA [neop]    
Tumor Sample [tisu]    
Assessed [acty]    
m2 [qnco]    
SHP-1 [gngm]    
Directly [qlco]    
m2 [qnco]    
Decreased [qnco]    
Proliferative [patf]    
Activity [ftcn]    
m2 [qnco]    
Effects [qlco]    
Treated [ftcn]    
Hepatocellular Carcinoma cell [cell]    
m2 [qnco]    
Sensitivity [patf]    
target drug [medd]    
SHP-1 [gngm]    
Activation [acty]    
Sphere [spco]    
Forming [ftcn]    
Activity [ftcn]    
Hepatocellular Carcinoma cell [cell]    
m2 [qnco]    
Clinical findings [sosy]    
Suggest [idcn]    
m2 [qnco]    
ACT [topp]    
Early Recurrence [fndg]    
Patients [podg]    
HEPATOCELLULAR CARCINOMA [neop]    
Known [qlco]    
Risk Factors [qnco]    
SHP-1 [gngm]    
m2 [qnco]    
arrested [dsyn]    
Nuclear [spco]    
function [phsf]    
m2 [qnco]    
Efficacy [qlco]    
target drug [medd]    
Targeting [ftcn]    
m2 [qnco]    
SHP-1 [gngm]    
NEW [qlco]    
Therapeutic [topp]    
insights [menp]    
Patients [podg]    
HEPATOCELLULAR CARCINOMA [neop]    
